<DOC>
	<DOCNO>NCT01451593</DOCNO>
	<brief_summary>Optic neuritis cause inflammation optic nerve cause loss vision affect eye . It often associate multiple sclerosis . Loss vision attack optic neuritis cause damage nerve fibre optic nerve . There number factor contribute nerve fibre damage include increased level sodium within , block sodium entry could help protect damage . The purpose study determine whether phenytoin ( block sodium entry cell ) protect loss nerve fibre prevent loss vision optic neuritis .</brief_summary>
	<brief_title>Neuroprotection With Phenytoin Optic Neuritis</brief_title>
	<detailed_description>Demyelinating optic neuritis common cause acute reversible visual loss young adult Northern European Origin . There strong association multiple sclerosis 75 % British adult acute clinically isolate optic neuritis go develop MS long term follow . Equally , 70 % MS patient clinical evidence optic nerve involvement course illness . The pathology acute inflammatory lesion comparable plaque find elsewhere CNS MS . The retina optic nerve therefore represent discrete compartment CNS affect disease process easily study use combination clinical , electrophysiological imaging technique . There good evidence axonal neuronal degeneration primary pathological process lead irreversible disability MS . Experimental model demonstrate numerous mechanism axonal loss include adaptive change demyelinate axonal membrane , particular increase density sodium channel lead increased concentration intraaxonal sodium ion . Partial blockade voltage gate sodium channel drug phenytoin show neuroprotective several experimental model inflammatory axonal injury . The retinal nerve fibre layer unique CNS myelinated therefore ideal biomarker process neurodegeneration neuroprotection . Imaging retinal nerve fibre layer use optical coherence tomography optic nerve use MRI demonstrate acute optic neuritis associate significant volume loss , correlate well impaired visual function . The primary aim trial ass whether sodium channel blockade phenytoin neuroprotective effect axonal loss attack acute demyelinate optic neuritis . Secondary aim ass whether phenytoin improve visual outcome remyelination ass safety treatment . 90 patient acute optic neuritis recruit double blind placebo control trial patient randomly allocate receive either phenytoin placebo 3 month . Recruitment take place two trial site Sheffield London . The trial power detect 50 % beneficial effect primary outcome measure . Outcome measure entry 6 months.Bias minimize blind assess physician patient use active placebo treatment identical appearance .</detailed_description>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Optic Neuritis</mesh_term>
	<mesh_term>Neuritis</mesh_term>
	<mesh_term>Phenytoin</mesh_term>
	<criteria>Diagnosis acute optic neuritis Visual acuity affect eye ≤ 6/12 Corrected vision normal eye ≥ 6/6 No history optic neuritis ocular disease either eye ≤ 14 day since onset visual loss Contraindication know allergy Phenytoin Contraindication MRI Use calcium channel sodium channel blocker past 2 month Corticosteroid use past 2 month Tysabri infusion past 3 month MS major temperature dependent disability Relapsing remit MS great 10 yrs duration EDSS &gt; 3 Pregnancy Breast Feeding Significant cardiac , renal liver abnormality</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>Optic neuritis</keyword>
	<keyword>Multiple sclerosis</keyword>
	<keyword>Retinal nerve fibre layer</keyword>
	<keyword>Axonal loss</keyword>
	<keyword>Neuroprotection</keyword>
	<keyword>Phenytoin</keyword>
	<keyword>MRI</keyword>
	<keyword>Optical coherence tomography</keyword>
	<keyword>Sodium Channel Blockers</keyword>
</DOC>